Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 200 clinical trials
Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.

Double blind single center clinical trial to compare the incidence of radial artery occlusion (RAO) using standard doses of Unfractionated Heparin (UFH) vs. high doses of UFH.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke

of the important pathogenesis of PIS. Heparin can reduce the incidence of post-stroke embolism, but its benefits are offset by the risk of hemorrhage due to the high risk of hemorrhage. The 2013AHA

  • 0 views
  • 25 Jan, 2021
  • 6 locations
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

Coronary angiography is performed to evaluate for obstructive coronary artery disease. This is commonly performed via the transfemoral or transradial approach with the latter increasing in frequency. One of the most common complications of transradial access is radial artery occlusion occurring in ~5% of patients which prohibits the use of …

  • 11 views
  • 26 Jan, 2021
  • 1 location
Nebulized Heparin for COVID19-associated Acute Respiratory Failure

The objective of the current study is to investigate the utilization of nebulized heparin to circumvent pathologic changes in COVID-19 and prevent harmful effects possible with systemic

  • 0 views
  • 20 Jun, 2021
  • 1 location
Polytetrafluoroethylen (PTFE) Vascular Prostheses With Heparin Bonded Luminal Surfaces vs Crude ePTFE

room for improvement in CLI patients in the absence of an suitable autologous vein in whom endovascular repair failed. Recently, PTFE with heparin-bound to the luminal surface (Hb-PTFE

  • 5 views
  • 22 Jan, 2021
  • 13 locations
Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection

predominate, especially in the severe forms of COVID-19. Thus, the investigators hypothesized that the use of heparin and tocilizumab could potencially reduce inflammation and thrombogenesis in patients with

  • 0 views
  • 01 Mar, 2021
  • 3 locations
Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery

In cardiovascular surgery, patients are anticoagulated with heparin during cardiopulmonary bypass, subsequently, anticoagulation is reversed with protamine to reduce bleeding due to residual

  • 0 views
  • 27 Jan, 2021
  • 1 location
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)

To evaluate the efficacy of oral colchicine combined with intraoperative infusion of dexamethasone, low molecular weight heparin and 5-FU during vitrectomy for management of established

  • 5 views
  • 07 Nov, 2020
  • 1 location
Hamburg Edoxaban for Anticoagulation in COVID-19 Study

strategy = low-dose low-molecular weight heparin [LMWH], ambulatory no anticoagulation, i.e. placebo within this trial) in reduction of morbidity and mortality endpoints in patients with COVID-19.

  • 0 views
  • 26 Jan, 2021
  • 8 locations
The Use of Tetrasodium EDTA Catheter Lock Solution for Patients on Home Parenteral Nutrition:Ease of Use and Cost Analysis

. They include solutions primarily aimed at reducing thrombosis, such as heparin and citrate, and others primarily aimed at reducing infection such as ethanol and antibiotics (for example, taurolidine

  • 0 views
  • 26 Jan, 2021
  • 1 location